Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|119|18|3377-3384

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.18, 2013-09, pp. : 3377-3384

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Time from Nephrectomy as a Prognostic Factor in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapies: Overall Results from a Large Cohort of Patients

By  

Oncology, Vol. 88, Iss. 3, 2014-11 ,pp. : 133-138

Karger

Access to resources Recommend Favorite

Comparative outcomes of everolimus, temsirolimus and sorafenib as second targeted therapies for metastatic renal cell carcinoma: a US medical record review

By Wong Michael K.   Yang Hongbo   Signorovitch James E.   Wang Xufang   Liu Zhimei   Liu Nathan S.   Qi Cynthia Z.   George Daniel J.  

Current Medical Research and Opinion, Vol. 30, Iss. 4, 2014-04 ,pp. : 537-545

Informa Healthcare

Access to resources Recommend Favorite

p21‐activated kinase 1 predicts recurrence and survival in patients with non‐metastatic clear cell renal cell carcinoma

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 5, 2015-05 ,pp. : 447-453

John Wiley & Sons Inc

Access to resources Recommend Favorite

Retrospective Analysis of Fifth-Line Targeted Therapy Efficacy in Patients with Metastatic Renal Cell Carcinoma

By  

Urologia Internationalis, Vol. 98, Iss. 2, 2016-03 ,pp. : 184-190

Karger

Access to resources Recommend Favorite

Computerized Tomography Measurement of Visceral Adiposity Predicts Plasma Adiponectin Levels and Metastatic Disease in Patients with Clear Cell Renal Cell Carcinoma

By  

Current Urology, Vol. 2, Iss. 4, 2009-02 ,pp. : 188-193

Karger

Access to resources Recommend Favorite